SBIR-STTR Award

Dielectrophoretic Microfluidic Protein Analysis System
Award last edited on: 11/19/2010

Sponsored Program
SBIR
Awarding Agency
DOD : CBD
Total Award Amount
$849,977
Award Phase
2
Solicitation Topic Code
CBD09-104
Principal Investigator
Gregory Zeltser

Company Information

Physical Optics Corporation (AKA: POC~Mercury Mission Systems, LLC)

1845 West 205th Street
Torrance, CA 90501
   (310) 320-3088
   info@pocsports.com
   www.poc.com
Location: Multiple
Congr. District: 43
County: Los Angeles

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2009
Phase I Amount
$99,991
To address the U.S. Army CBD need for a low-cost, universal, robust, and fieldable device for rapid, reproducible identification of protein variants from biological samples with high throughput, Physical Optics Corporation (POC) proposes to develop a new Dielectrophoretic Microfluidic Protein Analysis (DiMiPA) system. The system is based on an electrodeless dielectrophoresis-based, continuous-flow protein separation technique followed by protein identification via detection of the separated protein bands by UV absorption spectrometry. The DiMiPA system will be composed of a microfluidic chip, AC power supply, miniature pump, and readout unit. The DiMiPA tool will rapidly (10 min) and with high resolution and reproducibility separate protein variants from a mixture, preparing them for identification by the readout unit. The DiMiPA system will be an inexpensive, portable, and easy-to-use automated instrument. In Phase I, POC will demonstrate the feasibility of the DiMiPA device by fabricating a prototype and demonstrating its capability to identify relative concentrations of allozymes of sulfotransferase (SULT1A1), SULT1A1*1 and SULT1A1*3, which differ from each other by a single amino acid, in a mixed sample. In Phase II, DiMiPA will be optimized to enhance system throughput and separation resolution and identify additional sets of allozymes besides those of SULT1A1.

Keywords:
Polymorphism, Protein Variants Separation, Microfluidics, Dielectrophoresis

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2010
Phase II Amount
$749,986
To address the U.S. Army CBD need for a low-cost, universal, robust, and fieldable device for rapid, reproducible identification of protein variants from biological samples with high throughput, Physical Optics Corporation (POC) proposes to develop a new Dielectrophoretic Microfluidic Protein Analysis (DiMiPA) system based on an electrodeless dielectrophoresis-based, continuous-flow protein separation technique followed by protein variants quantification and identification via detection of the separated protein bands by UV absorption spectrometry and enhanced Raman spectrometry with POC-designed SERS substrates. The DiMiPA system will be composed of a microfluidic chip, an AC power supply, a syringe pump, and a readout unit. The DiMiPA tool will rapidly (10 min) and with high resolution and reproducibility separate protein variants, preparing them for identification by the readout unit. The DiMiPA system will be an inexpensive, portable, and easy-to-use automated instrument. In Phase I, POC demonstrated the feasibility of the DiMiPA device by fabricating a prototype and demonstrating its capability to separate allozymes of sulfotransferase (SULT1A1), SULT1A1*1, and SULT1A1*3, which differ from each other by a single amino acid. In Phase II, DiMiPA will be optimized to enhance system throughput and identification resolution to identify allozymes of SULT1A1 and heat shock protein 70, HSP70-1A, and HSP70-1B.

Keywords:
Polymorphism, Protein Variants Separation, Microfluidics, Dielectrophoresis, Raman Spectroscopy, Sers Substrate